Cargando…
S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells
Osteosarcoma (OS), a common worldwide primary aggressive bone malignancy, arises from primitive transformed cells of mesenchymal origin and usually attacks adolescents and young adults. Methotrexate (MTX) is the anti-folate drug used as a pivotal chemotherapeutic agent in the treatment of OS. Howeve...
Autores principales: | Ding, Lu, Wang, Chengwei, Cui, Yong, Han, Xiaoping, Zhou, Yang, Bai, Jingping, Li, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919717/ https://www.ncbi.nlm.nih.gov/pubmed/29620168 http://dx.doi.org/10.3892/ijo.2018.4345 |
Ejemplares similares
-
Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
por: Hinton, Kristin, et al.
Publicado: (2023) -
Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
por: Yang, Xiao-rong, et al.
Publicado: (2015) -
CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells
por: Wang, Zeyu, et al.
Publicado: (2018) -
Involvement of epithelial–mesenchymal transition in liver fibrosis
por: Yu, Kangkang, et al.
Publicado: (2018) -
LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism
por: Zhang, Jinxue, et al.
Publicado: (2020)